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Frondoside A is a pentaoside having an acetyl moiety at the aglycon ring and xylose as a third mono-
saccharide residue. Cucumarioside A2-2 is a pentaoside having glucose as a third monosaccahride
unit. We compared the effects of frondoside A and A2-2 for cell death-inducing capability with close
attention paid to structure–activity relationships. Both frondoside A and A2-2 strongly induced
apoptosis of leukemic cells. Frondoside A-induced apoptosis was more potent and rapid than
A2-2-induced apoptosis. A2-2-induced but not frondoside A-induced apoptosis was caspase-depen-
dent. This suggests that holothurians may induce apoptosis of leukemic cells caspase-dependently
or -independently, depending on the holothurian structure.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is characterized by speciﬁc morphological and bio-
chemical changes with activation of the cysteine aspartyl prote-
ases family caspases [1]. This family includes two subclasses of
initiator and effector enzymes [2]. However, there is growing evi-
dence that apoptotic pathways also can be activated without par-
ticipation of caspases, through mechanisms involving activation
of other classes of proteases such as calpains (calcium-dependent
proteases), cathepsins, serine proteases, granzymes, etc. [3]. These
proteases often cooperate with caspases, but they also can pro-
voke characteristic apoptotic changes in a caspase-independent
manner [4].
Glycosides, substances consisting of a sugar moiety (carbohy-
drate chain) and triterpene or steroid aglycon are widely distrib-chemical Societies. Published by E
; ER, endoplasmic reticulum;
optosis-inducing factor
. Kwak); +7 4232 31 49 50 (V.
ik), jykwak@dau.ac.kr (J.-Y.uted in plants and have attracted the most attention. Triterpene
oligoglycosides were found in marine invertebrates belonging to
the class Holothurioidea in the animal kingdom and in some
sponges [5]. However, only a few papers regarding the structure
and biological activity of the holothurians have been published un-
til now.
Frondoside A, a major triterpene glycoside isolated from sea
cucumber Cucumaria frondosa, has a sulfate, acetoxy group at
C-16 of the aglycon, pentasaccharide chain, xylose at the third
monosaccharide residue, and 3-O-methylglucose as terminal
monosaccharide residue [6]. Cucumarioside A4-2, a glycoside iso-
lated from Cucumaria japonica, has monosulfated pentaoside hav-
ing 16-keto group in aglycon and glucose residue as a third
monosaccahride unit in the carbohydrate chain [7]. The sub-
stance A2-2 is probably biogenetically connected with A4-2 and
has 3-O-methylglucose instead of glucose as the terminal mono-
saccharide unit [7]. The main structural difference between
frondoside A and A2-2 is in the functional group at C-16 of the
aglycon (acetoxy or keto group) and the third carbohydrate unit
in the carbohydrate chain. In this study, we observed differences
in the potency of the cytotoxicity and apoptotic pathways acti-
vated by frondoside A and A2-2.lsevier B.V. All rights reserved.
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2.1. Reagents
The chemical structures of frondoside A, A2-2, and A4-2 are
shown in Fig. 1. The frondoside A and cucumariosides were ex-
tracted and puriﬁed as previously described [8,9]. Annexin-V was
from BD Biosciences Clontech (Palo Alto, CA, USA). Anti-poly
(ADP ribose) polymerase (PARP) and cytochrome c antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Antibodies against procaspases were purchased from Cell Signaling
Technology (Beverly, MA, USA). The inhibitors zDEVD-fmk, zVAD-
fmk, and zIETD-fmk were purchased from Calbiochem (San Diego,
CA. USA). All other chemicals were purchased from Sigma (St.
Louis, MO, USA).
2.2. Cell culture
HL-60, NB4, and THP-1 cells were maintained in RPMI 1640
supplemented with 10% fetal bovine serum (FBS) and with antibi-
otic–antimycotic cocktail and were incubated at 37 C in a humid-
iﬁed atmosphere of 5% CO2.
2.3. Neutral red release assay
Cytotoxicity was studied using the neutral red release assay
according to Borenfreund and Puerner [8]. The neutral red re-Fig. 1. Chemical structure of triterpene glycoside frondoside A, A2-2, and A4-2.lease assay is an in vitro viability test, based on the incorporation
of neutral red stain into the lysosomes of viable cells. Brieﬂy,
1  104 exponentially growing cells were seeded in 96-well
plates with various concentrations of frondoside A, A2-2, or A4-
2 for 24 h. Cells were washed with 200 ll PBS and ﬁltered neu-
tral red stock solution (4%, w/v, 0.9% NaCl) was diluted 1:60 in
serum-free media and added to each well. After 4 h incubation,
cells were washed twice and 150 ll of lysing solution was added
(50%, v/v, ethanol with 1%, v/v, acetic acid) to the wells. Absor-
bance at 540 nm was measured using a spectrophotometric
microplate reader. All results were expressed as percentage of
viable cells.
2.4. Apoptosis assay
Leukemia cells were treated with different concentrations of
frondoside A, A2-2, or A4-2 for 6 h. After incubation, cells were har-
vested, washed with phosphate buffered saline (PBS, pH 7.4), cen-
trifuged, and stained with annexin V-ﬂuorescein-isothiocyanate
(FITC) and propidium iodide (PI) in 100 ll of binding buffer
(10 mM HEPES, pH 7.4/140 mM NaCl/2.5 mM CaCl2) for 15 min in
the dark. The samples were analyzed by ﬂow cytometry using a
FACScan ﬂow cytometer, which differentiated early apoptotic cells
(annexin V-FITC positive), late apoptotic and/or necrotic cells (an-
nexin V-FITC and PI positive), and viable cells (unstained). The
apoptotic cells were determined as annexin V+/PI and annexin
V+/PI+ cells.2.5. Western blot analysis
HL-60 cells were harvested, washed with ice-cold PBS, and trea-
ted with lysis buffer containing 20 mM Tris (pH 8.0), 137 mM NaCl,
1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100 accom-
panied by protease inhibitors. Proteins were separated by 10% or
18% SDS–PAGE and transferred to nitrocellulose membranes. The
membranes were blocked with a blocking buffer (10 mM Tris–
HCl, 0.15 M NaCl, 0.1% NaN3, and 5% skim milk) for 1 h at 25 C
and incubated with primary polyclonal antibodies directed against
procaspase-3, -8, -7, -9, and -12, the cleavage form of caspases-3,
PARP, cytochrome c, and b-actin in blocking buffer overnight at
4 C. The membranes were incubated with the secondary antibod-
ies for 1 h at 25 C. The signals were detected using ECL chemilumi-
nescence following the manufacturer’s instructions.2.6. Mitochondrial membrane permeability assay
HL-60 cells (1  106/ml) were incubated with 40 nM of 3,30-
dihexyloxacarbocyanine iodide [DiOC6(3), Molecular probes] for
30 min at 37 C and then washed with PBS. Stained cells were ana-
lyzed by ﬂow cytometry.2.7. Detection of cytochrome c in cytosolic fraction
Cytosolic and mitochondrial proteins were separated as de-
scribed previously [9]. In brief, cells treated with frondoside A,
A2-2, or etoposide for 6 h were collected and resuspended in mito-
chondrial isolation buffer (20 mM HEPES–KOH, pH 7.5, 210 mM
sucrose, 70 mM mannitol, 1 mM EDTA, 1 mM DTT, 1.5 mM MgCl2,
10 mM KCl) and protease inhibitor cocktail (Boehringer Mann-
heim) supplemented with 10 lM digitonin. Suspensions were
incubated at 37 C for 5 min and centrifuged at 12000g for
15 min. The supernatant (cytosolic fraction) was collected for wes-
tern blotting.
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Data are expressed as mean ± standard deviation (S.D.). Statisti-
cal analyses were carried out using Student’s t-tests. Time-course
and dose-response were analyzed by one-way analysis of variance
(ANOVA) with the post-test. A P value of <0.05 was considered
signiﬁcant.
3. Results
3.1. Cytotoxic effects of frondoside A and cucumariosides
To explore the effects of frondoside A, A2-2, and A4-2 on leuke-
mic cell viability, HL-60 cells were cultured with different concen-
trations of these agents for 24 h and cytotoxicity was measured by
neutral red release assay. As shown in Fig. 2A, frondoside A had a
dose-dependent inﬂuence on HL-60 viability and totally inhibited
cell viability at concentrations at or above 2 lM (ANOVA,
F = 2206, P < 0.001). A2-2 and A4-2 also had a cytotoxic effect (AN-
OVA, A2-2; F = 3153, P < 0.001, A4-2; F = 2511, P < 0.001) but it was
less than that for frondoside A. It also showed that frondoside AFig. 2. Effects of frondoside A and cucumariosides on cytotoxicity and apoptosis in
leukemic cells. (A) HL-60 cells were treated with different concentrations of the
frondoside A, A2-2, or A4-2 for 24 h. Neutral red solution was added to the washed
cells. After 4 h incubation, the viability of cells was detected by measuring
absorbance at 540 nm. (B) HL-60 cells were treated with frondoside A (1 lM), A2-2
(5 lM), or A4-2 (5 lM) for 6 h. The cells were then subject to annexin V-FITC and PI
staining and apoptosis was measured by ﬂow cytometry. Representative experi-
ments are shown. (C) Leukemic cells were treated with or without frondoside A, A2-
2, or A4-2 as shown in panel B. The results represent the mean ± S.D. of three
independent experiments. *P < 0.01 compared to A2-2 (Student’s t-test).treatment of HL-60 cells increased the sub-G1 fraction (data not
shown). Treatment with 5 lM A2-2 or A4-2 increased the sub-G1
fraction as much as 1 lM frondoside A treatment.
3.2. Apoptotic effect of frondoside A and cucumariosides on leukemia
cells
The apoptosis rate was determined by measuring the extent of
annexin V-FITC binding. The apoptotic rates of HL-60 cells were in-
creased after 6 h of culture by 1 lM of frondoside A, 5 lM of A2-2,
and 5 lM of A4-2 (Fig. 2B). Four different leukemia cell lines were
tested for the ability of frondoside A to induce apoptosis. HL-60,
NB4, THP-1, and K562 cells were treated with 1 lM frondoside A
for 6 h (Fig. 2C). Frondoside A had a stronger apoptotic effect on
HL-60 and NB4 cells than on THP-1 cells. The apoptosis of other
leukemic cells was also induced by A2-2 and A4-2, although higher
concentrations were needed than that of frondoside A to induce a
degree of apoptosis similar to frondoside A.
The frondoside A-provoked apoptosis in HL-60 cells and THP-1
cells in a dose-dependent manner (0.5–5 lM for 6 h, Fig. 3A).
Frondoside A-induced a rapid increase in the proportion of apopto-
tic cells (up to 90.2% at 1 lM concentration for HL-60 cells) while
the apoptotic rate in THP-1 cells at the same concentration was
60% (ANOVA, HL-60 cells; F = 218.2, P < 0.001, THP-1 cells;
F = 80.0, P < 0.001). At the same concentrations, the A2-2 and A4-2
induced respectively, 15 ± 5% and 42 ± 7% cell death in HL-60 cells.
At 5 lM, A2-2 and A4-2-induced apoptosis was evident after 6 h
treatment of HL-60 cells (ANOVA, A2-2; F = 293.2, P < 0.001, A4-2;
F = 161.2, P < 0.001).
Next, we tested the time-dependence of the effect of frondoside
A at different concentrations on HL-60 cells (Fig. 3B). At low con-
centrations (0.1 lM), frondoside A-induced apoptosis in only 10%
of cells and the amount did not change after 24 h of incubation.
At 0.5 lM concentration (0.5–1 h incubation), frondoside A signif-
icantly increased the proportion of cells in apoptosis and for 24 h
incubation slightly increased the proportion of cells in apoptosis
to 50% (ANOVA, F = 34.6, P < 0.001). At high concentrations
(1 lM), frondoside A elicited apoptosis in 50% of cells as early
as 30 min after incubation and this increased to 75% after 6 h incu-
bation (ANOVA, F = 179.0, P < 0.001). At 2 h after treatment, A2-2
(3 lM) had induced 60–80% of HL-60 cells to undergo apoptosis
(ANOVA multiple comparison, P < 0.001), while A4-2 at the same
concentration induced only 15% of cells to undergo apoptosis (AN-
OVA multiple comparison, P = 0.494). Signiﬁcant increases in cell
death were also observed at 6 h after A2-2 or A4-2 treatment.
Although A4-2 was less active than A2-2, it showed similar apopto-
sis-inducing activity in HL-60 cells. These results indicate that
frondoside A is more toxic to leukemic cells than cucumariosides.
3.3. Effects of frondoside A on intracellular levels of apoptotic proteins
in HL-60 cells
We measured the staining of cells using DiOC6(3), which re-
ﬂects changes in mitochondrial membrane potential. As shown in
Fig. 4A, a mitochondrial membrane permeability assay did not
show signiﬁcant changes in DiOC6(3) staining of HL-60 cells at
6 h after treatment with frondoside A and cucumariosides. In addi-
tion, the accumulation of cytochrome c in the cytosolic fraction
isolated from frondoside A-, A2-2-, or A4-2-treated HL-60 cells
was not observed, whereas cells treated with etoposide showed a
marked increase in the presence of cytochrome c in the cytosolic
fraction. Next, we compared time courses of apoptosis and activa-
tion of procaspases in frondoside A-treated HL-60 cells. The levels
of all tested procaspase-3, -8, and -9 proteins in lysates from
frondoside A-treated (for up to 2 h) HL-60 cells were not changed,
whereas, at these time points, frondoside A-induced apoptosis in
Fig. 3. Dose- and time-dependent apoptotic effects of frondoside A and cucumariosides on leukemic cells. (A) In the left panel, HL-60 cells and THP-1 cells were treated with
the indicated concentrations of the frondoside A for 6 h. In the right panel, HL-60 cells were treated with the indicated concentrations of the A2-2 or A4-2 for 6 h. (B) In the left
panel, HL-60 cells were treated with different concentrations of the frondoside A for the indicated times. In the right panel, HL-60 cells were treated with 3 lM of A2-2
(ANOVA, F = 204.6, P < 0.001) or A4-2 (ANOVA, F = 133.4, P < 0.001) for the indicated times.
*P < 0.001 compared to untreated control (ANOVA).
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frondoside A, however, the levels of procaspases-8 and -3 signiﬁ-
cantly decreased. Moreover, the time-dependent changes in the
levels of cleaved caspase-3 and PARP, a typical substrate for cas-
pase-3, were closely related to the changes in procaspase-3. These
results suggest that frondoside A initiates apoptosis in a caspase-
independent manner. We also determined whether caspase-7,
which is also activated in response to endoplasmic reticulum
(ER) stress, is also activated in response to frondoside A. The
change in cleavage of procaspase-7 in the frondoside A-treated
HL-60 cells was similar to that of caspase-3 in time-dependent
experiments. In comparison, western blot analysis of HL-60 cells
treated with A2-2 or A4-2 showed that the cleavages of procas-
pase-3 and PARP but not procaspases-8, -9, and -12 were signiﬁ-
cantly increased after 6 h treatment (Fig. 4C).
3.4. Effects of caspase inhibitors on frondoside A-induced apoptosis in
HL-60 cells
HL-60 cells were treated with a high concentration of zDEVD-
fmk (200 lM), a caspase-3 inhibitor, alone or in combination with
frondoside A for 6 h. Depending on the time point and the frondo-
side A concentration used, inhibition of cell death with zDEVD-fmk
varied between 0% and 10%, indicating that cell death is largely
caspase-independent (Fig. 5A). zVAD-fmk (200 lM) also did not
show signiﬁcant inhibition of the apoptosis induced by frondoside
A. As positive controls, zDEVD-fmk (200 lM) or zVAD-fmk
(200 lM) each prevented the apoptosis of HL-60 cells induced by
etoposide, reducing the level of apoptotic cells from 70% to 15%
and 10%, respectively. In comparison, when HL-60 cells were pre-
incubated with a broad spectrum inhibitor of caspase activity fol-
lowed by a 6 h exposure to A2-2 or A4-2 (3–5 lM), zVAD-fmkblocked A2-2- or A4-2-induced apoptosis. A similar result was ob-
tained when zDEVD-fmk was used, although the magnitude of
the blocking effect by zDEVD-fmk was less than that by zVAD-
fmk (Fig. 5B). In contrast, z-IETD-fmk (a caspase-8 inhibitor) was
only marginally effective in preventing apoptosis of HL-60 cells in-
duced by A2-2 or A4-2. Next, we investigated whether caspase
inhibitors block activation of caspases by western blot because
frondoside A and A2-2 reduced procaspase-3, and increased
cleaved caspase-3 and PARP cleavage (Fig. 4B and C). As shown
in Fig. 5C, decrease of procaspase-3, increase of cleaved caspase-
3, and cleavage of PARP induced by A2-2 or frondoside A, were efﬁ-
ciently blocked by either zDEVD-fmk (200 lM) or zVAD-fmk
(200 lM). Moreover, frondoside A-induced cleavage of procas-
pase-8 was blocked by zVAD-fmk. These results support caspase-
independent activation of apoptosis by frondoside A and the cas-
pase-3-dependent activation of apoptosis by cucumariosides.
4. Discussion
On the basis of our previous observations regarding the impor-
tance of the structure of the aglycon and carbohydrates in confer-
ring membranolytic activity [10], we compared the cytotoxicity of
two holoturians against various leukemia cells. The LD50 of frondo-
side A and cucumarioside for mice was 9.9 mg/kg and 10 mg/kg,
respectively after intraperitoneal injection [7,11]. This suggests
that acute toxicity for these two compounds is similar. On the
other hand, our unpublished study showed that hemolytic activity
of frondoside A was three times more potent than A2-2, which is
consistent with the data on anti-tumoral effects obtained from
our present study. The LD50 of frondoside A in HL-60 cells was in
the low or submicromolar range and was approximately 5–10 fold
lower than LD50s for cucumariosides A2-2 and A4-2.
Fig. 4. Caspase-independent apoptosis in frondoside A-treated leukemic cells. (A) HL-60 cells were treated with frondoside A (1 lM), A2-2 (3 lM), A4-2 (3 lM), or etoposide
(10 lM) for 6 h. In the upper panel, cells were incubated with 40 nM DiOC6(3) for 30 min and subjected to ﬂow cytometry. In the lower panel, the levels of cytochrome c
(12.5 kDa) in the cytosolic fraction were measured by western blot. As a positive control, 10 lM etoposide was used. Actin was used as loading control for the cytosolic
fraction. (B) HL-60 cells were treated for the indicated times with frondoside A (1 lM) or or etoposide (10 lM) for 6 h. (C) In the left panel, HL-60 cells were treated with A2-2
(3 lM), A4-2 (3 lM), or etoposide for 6 h. In the right panel, cells were treated with A2-2 (3 lM) for the indicated times or etoposide for 6 h. The expression of caspase-
associated proteins was detected by western blot analysis. The expression of b-actin protein served as a loading control.
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chain are very important for anti-tumor activity. It has been re-
ported that the presence of acetyl groups usually increases cyto-
toxic potency [12]. Similarly, monosulfated cucumariosides A2-2
and A4-2 were among the most active compounds for stimulating
peritoneal macrophage lysosomal activity, while desulfation of
their carbohydrate moiety completely abolished this activity [7].
Our study also indicated that the acetyl group at C-160 of the agly-
con in frondoside A may play a signiﬁcant role in frondoside’s cyto-
toxicity and caspase activation since frondoside A had more potent
effects than A4-2 on cytotoxicity, cell cycle changes and apoptosis
but led to no caspase activation before early apoptosis. Frondoside
A contains xylose in its carbohydrate residues, but the some
changes in the carbohydrate residues may not play a signiﬁcant
role in the cytotoxicity of frondoside A and cucumariosides since
the A2-2 and A4-2 differ only in the structure of their terminal
monosaccharide residue (glucose and methylglucose, respec-
tively). They show some differences in apoptotic activities butsimilar effects on procaspase cleavage and mitochondrial
permeability.
In the presence of frondoside A, annexin-V positivity preceded
the loss of procaspases-8 and -3 after 6 h of treatment. Moreover,
the annexin-V positivity was not inhibited by zVAD-fmk, whereas
both the annexin-V positivity and cleavage of caspases induced by
cucumariosides was efﬁciently blocked by caspase inhibitors. In
addition, we observed inhibitory activity of zDEVD-fmk or zVAD-
fmk in the frondoside A-induced cleavage of procaspases and PARP
by Western blotting, indicating that the caspase inhibitors effec-
tively blocked frondoside A-provoked activation of caspases. These
results suggest that frondoside A caused caspase-independent cell
death. Recently, Li et al. have shown that treatment of human pan-
creatic cancer cells with low concentration of frondoside A for 24 h
or 48 h induces apoptosis of pancreatic cancer cells through the
mitochondrial and activation of caspase cascade [13]. They also
reported strong annexin V staining in the pancreatic cancer cells
after frondoside A treatment for 3 h [13]. Caspase-3 is an effector
Fig. 5. Effects of caspase inhibitors on frondoside A- or cucumarioside-induced
apoptosis of HL-60 cells. (A) HL-60 cells were pretreated with or without 200 lM
zDEVD-fmk or 200 lM zVAD-fmk for 1 h and then challenged with frondoside A
(1 lM) or etoposide (10 lM) for 6 h. Representative experiments are shown. (B)
Cells were pretreated with 100 lM zDEVD-fmk or 50 lM zVAD-fmk for 1 h and
further treated with 3 or 5 lM of A2-2 or A4-2 for 6 h. Results represent the
mean ± S.D. of three independent experiments. (C) Cells were pretreated with
caspase inhibitors as in panel A and further treated with 1 lM frondoside A or 5 lM
A2-2 for 6 h.
*P < 0.05 (Student’s t-test).
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study, zDEVD-fmk and zVAD-fmk did not protect signiﬁcantly
against the apoptotic effects of frondoside A, and it only reduced
cucumarioside-induced cell death. Although caspase activation is
considered a hallmark of apoptotic cell death, other less-deﬁned
cell death pathways have been described that appear not to require
caspase activation. Recently, mitochondria-mediated, caspase-
independent apoptotic pathways were described [14]. The loss of
mitochondrial transmembrane potential is generally mediated by
opening of the mitochondrial permeability transition pores and
as a consequence, the release of apoptogenic molecules such as
apoptosis-inducing factor (AIF) or cytochrome c with subsequent
caspase-independent or -dependent nuclear degradation [15]. In
the present study, frondoside A- or cucumarioside-induced apop-
tosis occurred in the absence of mitochondrial transmembrane po-
tential changes, the cytosolic accumulation of cytochrome c, andcaspase-9 activation, likely excluding the involvement of AIF and
cytochrome c. In addition to mitochondria, other organelles, such
as ER and lysosomes are targets of apoptotic initiation. Caspase-
12 is proteolytically activated by upstream initiator caspase-7 fol-
lowing ER stress and calpain activation [16]. However, the cleavage
of procaspase-7 was not observed after 2 h treatment with frondo-
side A, as there was no loss of procaspases-8 and -3 at the same
time point. Moreover, frondoside A-induced apoptosis was not
abrogated by the ER stress inhibitor, salubrinal (data not shown).
Together, these results suggest that frondoside A induces apoptosis
in HL-60 cells through a mechanism distinct from extrinsic and
intrinsic apoptosis pathways.
In conclusion, the data presented in this study indicate that
frondoside A and cucumariosides both possess antileukemic prop-
erties by inducing apoptosis. The mechanism of this action is
uncertain and will be explored in future studies. Caspase-indepen-
dent anti-leukemic agents, such as frondoside A will be useful to
overcome chemoresistance such as occurs in acute myeloid leuke-
mia, where resistance to chemotherapy is associated with defects
in both the extrinsic and intrinsic pathways of apoptosis.Acknowledgements
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